サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1501241

バイオ活性タンパク質およびペプチドの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 由来別、用途別、地域別

Bio Active Protein and Peptides Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 223 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
バイオ活性タンパク質およびペプチドの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 由来別、用途別、地域別
出版日: 2024年06月18日
発行: Fairfield Market Research
ページ情報: 英文 223 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のバイオ活性タンパク質およびペプチドの市場規模は、栄養価が高く健康的な食品を求める消費者の増加に伴い、力強い拡大を遂げています。この成長は、人口動態の変化、消費者の嗜好の進化、生産技術の進歩などが相まって、今後10年間も続くと予測されています。

高齢化に伴う慢性疾患の増加により、消費者は生物活性タンパク質やペプチドを含むより健康的な食事の選択肢を求めるようになっています。化粧品やパーソナルケア分野でこれらの栄養素に対する消費者の嗜好が高まっており、市場規模がさらに拡大しています。世界的に可処分所得水準が上昇し、1人当たりの食費が増加するにつれて、より多くの消費者がプレミアム健康志向製品を購入できるようになります。

健康、持続可能性、倫理的な理由からベジタリアンや肉食を避ける傾向が強まっているため、植物由来原料、特に大豆とエンドウ豆由来の原料の人気が高まっています。また、植物由来のタンパク質は一般的に動物由来のものよりも安価で抽出が容易であるため、メーカーにとって魅力的です。

当レポートでは、世界のバイオ活性タンパク質およびペプチド市場について調査し、市場の概要とともに、由来別、用途別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界のバイオ活性タンパク質およびペプチド市場の見通し、2018年～2031年

  • 世界のバイオ活性タンパク質およびペプチド市場の見通し、由来別、金額（10億米ドル）、2018年～2031年
  • 世界のバイオ活性タンパク質およびペプチド市場の見通し、用途別、金額（10億米ドル）、2018年～2031年
  • 世界のバイオ活性タンパク質およびペプチド市場の見通し、地域別、金額（10億米ドル）、2018年～2031年

第4章 北米のバイオ活性タンパク質およびペプチド市場の見通し、2018年～2031年

第5章 欧州のバイオ活性タンパク質およびペプチド市場の見通し、2018年～2031年

第6章 アジア太平洋のバイオ活性タンパク質およびペプチド市場の見通し、2018年～2031年

第7章 ラテンアメリカのバイオ活性タンパク質およびペプチド市場の見通し、2018年～2031年

第8章 中東・アフリカのバイオ活性タンパク質およびペプチド市場の見通し、2018年～2031年

第9章 競合情勢

  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • BASF SE
    • Seagarden AS
    • ADM
    • Ingredia SA
    • Rousselot S.A.S.
    • Peptan
    • Kerry Group plc
    • CP Kelco
    • Omega Protein Corporation
    • E.I. Du Pont De Nemours

第10章 付録

目次

The global market for bioactive proteins and peptides is experiencing robust growth as consumers increasingly seek out nutritional and healthy food options. This growth is projected to continue over the coming decade, driven by a combination of demographic shifts, evolving consumer preferences, and advances in production technologies.

Factors Influencing Market Growth

Several key factors are propelling the demand for bioactive proteins and peptides:

  • Aging Population: The rise in chronic diseases associated with aging is leading consumers to seek out healthier dietary options that include bioactive proteins and peptides.
  • Health and Wellness Trends: There is an increasing consumer preference for these nutrients in the cosmetics and personal care sectors, further expanding the market reach.
  • Economic Factors: As disposable income levels rise globally, alongside an increase in per capita food expenditure, more consumers are able to afford premium health-oriented products.
  • Plant-Based Trends: Plant source ingredients, particularly from soy and pea, are becoming more popular due to the growing trend towards vegetarian and meat-free diets for health, sustainability, and ethical reasons. Plant-derived proteins are also typically less expensive and easier to extract than animal sources, making them attractive to manufacturers.

Challenges in the Market

Despite robust growth, manufacturers face certain challenges:

  • Regulatory Environment: Stringent regulations increase operational costs and affect the overall efficiency of production and distribution.
  • Supply Chain Complexity: Issues within the supply chain can also pose significant hurdles for players in this market.

Regional Market Insights

North America is currently the leader in the global bioactive proteins and peptides market, attributed to its high demand for sports and nutritional foods. The busy lifestyle and work culture in this region have increased the consumption of ready-to-eat and functional beverages, creating significant opportunities for market players. However, other regions, including Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan, and the Middle East & Africa, also show promising growth potential.

Market Trends

The trend towards plant-sourced bioactive proteins and peptides is particularly strong, with this segment expected to see substantial year-on-year growth throughout the forecast period. The increasing physiological benefits and consumer preference towards vegetarian food contribute to this trend. Among applications, while functional foods remain popular, functional beverages are anticipated to see higher traction and growth, reflecting consumer desires for convenient, health-enhancing products.

Key Players in the Market

Leading companies in the global bioactive protein and peptides market include Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., Omega Protein Corporation, Bunge Ltd., E.I. Du Pont De Nemours and Company, Fonterra Co-operative Group Ltd., Royal DSM, and CHS Inc. These players are at the forefront of addressing consumer demands through innovation and are expanding their market presence through strategic initiatives and extensive research & development activities.

Market Segmentation

The market is segmented based on source and application, offering insights into consumer preferences and product functionality:

By Source

  • Plant Source
    • Cereals
    • Legumes

§ Soy Protein Concentrates

§ Soy Protein Isolates

§ Textured Soy Protein

    • Pseudo cereals
    • Brasssicaceae species
    • Others
  • Animal Source
    • Dairy products

§ Whey

§ Casein

§ Milk Protein Concentrate

    • Egg & Meat
    • Gelatin
    • Fish & Insects
    • Seafood

By Application

  • Functional Food
  • Functional Beverages
  • Dietary Supplements
  • Animal Nutrition
  • Personal Care
  • Others (Printing & Painting)

Table of Contents

1. Executive Summary

  • 1.1. Global Bio Active Protein and Peptides Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 3.1. Global Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Plant
      • 3.1.1.2. Animal
      • 3.1.1.3. Marine
  • 3.2. Global Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Functional Food
      • 3.2.1.2. Functional Beverages
      • 3.2.1.3. Dietary Supplements
      • 3.2.1.4. Animal Nutrition
      • 3.2.1.5. Personal Care
      • 3.2.1.6. Others (Printing & Painting)
  • 3.3. Global Bio Active Protein and Peptides Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 4.1. North America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Plant
      • 4.1.1.2. Animal
      • 4.1.1.3. Marine
  • 4.2. North America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Functional Food
      • 4.2.1.2. Functional Beverages
      • 4.2.1.3. Dietary Supplements
      • 4.2.1.4. Animal Nutrition
      • 4.2.1.5. Personal Care
      • 4.2.1.6. Others (Printing & Painting)
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 5.1. Europe Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Plant
      • 5.1.1.2. Animal
      • 5.1.1.3. Marine
  • 5.2. Europe Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Functional Food
      • 5.2.1.2. Functional Beverages
      • 5.2.1.3. Dietary Supplements
      • 5.2.1.4. Animal Nutrition
      • 5.2.1.5. Personal Care
      • 5.2.1.6. Others (Printing & Painting)
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Plant
      • 6.1.1.2. Animal
      • 6.1.1.3. Marine
  • 6.2. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Functional Food
      • 6.2.1.2. Functional Beverages
      • 6.2.1.3. Dietary Supplements
      • 6.2.1.4. Animal Nutrition
      • 6.2.1.5. Personal Care
      • 6.2.1.6. Others (Printing & Painting)
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 7.1. Latin America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Plant
      • 7.1.1.2. Animal
      • 7.1.1.3. Marine
  • 7.2. Latin America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Functional Food
      • 7.2.1.2. Functional Beverages
      • 7.2.1.3. Dietary Supplements
      • 7.2.1.4. Animal Nutrition
      • 7.2.1.5. Personal Care
      • 7.2.1.6. Others (Printing & Painting)
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Bio Active Protein and Peptides Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Plant
      • 8.1.1.2. Animal
      • 8.1.1.3. Marine
  • 8.2. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Functional Food
      • 8.2.1.2. Functional Beverages
      • 8.2.1.3. Dietary Supplements
      • 8.2.1.4. Animal Nutrition
      • 8.2.1.5. Personal Care
      • 8.2.1.6. Others (Printing & Painting)
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2024
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. BASF SE
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Therapy Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Seagarden AS
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Therapy Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. ADM
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Therapy Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Ingredia SA
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Therapy Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Rousselot S.A.S.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Therapy Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Peptan
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Therapy Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. Kerry Group plc
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Therapy Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. CP Kelco
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Therapy Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Omega Protein Corporation
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Therapy Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. E.I. Du Pont De Nemours
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Therapy Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations